Generation and characterization of a humanized ACE2 mouse model to study long‐term impacts of SARS‐CoV‐2 infection
Journal of Medical Virology · 2024
DOI: 10.1002/jmv.29349 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Chang-Yong Choi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Surgery, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS, NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
Although the COVID‐19 pandemic has officially ended, the persistent challenge of long‐COVID or post‐acute COVID sequelae (PASC) continues to impact societies globally, highlighting the urgent need for ongoing research into its mechanisms and therapeutic approaches. Our team has recently developed a novel humanized ACE2 mouse model (hACE2ki) designed explicitly for long‐COVID/PASC research. This model exhibits human ACE2 expression in tissue and cell‐specific patterns akin to mouse Ace2. When we exposed young adult hACE2ki mice (6 weeks old) to various SARS‐CoV‐2 lineages, including WA, Delta, and Omicron, at a dose of 5 × 10 5 PFU/mouse via nasal instillation, the mice demonstrated distinctive phenotypes characterized by differences in viral load in the lung, trachea, and nasal turbinate, weight loss, and changes in pro‐inflammatory cytokines and immune cell profiles in bronchoalveolar lavage fluid. Notably, no mortality was observed in this age group. Further, to assess the model's relevance for long‐COVID studies, we investigated tau protein pathologies, which are linked to Alzheimer's disease, in the brains of these mice post SARS‐CoV‐2 infection. Our findings revealed the accumulation and longitudinal propagation of tau, confirming the potential of our hACE2ki mouse model for preclinical studies of long‐COVID.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pediatric Surgery, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Department of Neurology, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Molecular and Comparative Pathobiology, The Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
- Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
- Department of Material Science and Engineering, Johns Hopkins Whiting School of Engineering, Institute for NanoBioTechnology, Baltimore, Maryland, USA.
ORCID-Profile: Hongpeng Jia
Förderung
- NIA NIH HHS
- NIH HHS
- NIAID NIH HHS
- NINDS NIH HHS
Zitieren
APA
Choi, C. Y., Gadhave, K., Villano, J., Pekosz, A., Mao, X., & Jia, H. (2024). Generation and characterization of a humanized ACE2 mouse model to study long‐term impacts of SARS‐CoV‐2 infection. Journal of Medical Virology. https://doi.org/10.1002/jmv.29349
Vancouver
Choi CY, Gadhave K, Villano J, Pekosz A, Mao X, Jia H. Generation and characterization of a humanized ACE2 mouse model to study long‐term impacts of SARS‐CoV‐2 infection. Journal of Medical Virology. 2024. doi:10.1002/jmv.29349
BibTeX
@article{Choi2024,
author = {Choi, Chang-Yong and Gadhave, Kundlik and Villano, Jason and Pekosz, Andrew and Mao, Xiaobo and Jia, Hongpeng},
title = {Generation and characterization of a humanized ACE2 mouse model to study long‐term impacts of SARS‐CoV‐2 infection},
journal = {Journal of Medical Virology},
year = {2024},
doi = {10.1002/jmv.29349}
}
EUVIMED